Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Alexion receives FDA approval for Soliris to treat atypical Hemolytic Uremic Syndrome

Alexion receives FDA approval for Soliris to treat atypical Hemolytic Uremic Syndrome

YM BioSciences total revenue decreases to $1.5 million for fiscal 2011

YM BioSciences total revenue decreases to $1.5 million for fiscal 2011

One in five cancer patients more likely to develop venous thromboembolism

One in five cancer patients more likely to develop venous thromboembolism

Common symptoms of pediatric feeding disorder

Common symptoms of pediatric feeding disorder

NEJM publishes data from Vertex INCIVEK Phase 3 study on genotype 1 chronic hepatitis C

NEJM publishes data from Vertex INCIVEK Phase 3 study on genotype 1 chronic hepatitis C

Acceleron commences ACE-536 Phase 1 clinical trial in anemia

Acceleron commences ACE-536 Phase 1 clinical trial in anemia

Micronutrient powder helps prevent malnutrition in children up to two years old, study review shows

Micronutrient powder helps prevent malnutrition in children up to two years old, study review shows

Anthem proposes double-digit rate increase in Conn.; Mass. bill would cut payments to high-cost providers

Anthem proposes double-digit rate increase in Conn.; Mass. bill would cut payments to high-cost providers

New blood test could help identify babies at risk of sickle cell disease

New blood test could help identify babies at risk of sickle cell disease

Tick-borne disease in US blood supply

Tick-borne disease in US blood supply

NOXXON to commence NOX-H94 Phase I trial in anemia of chronic disease

NOXXON to commence NOX-H94 Phase I trial in anemia of chronic disease

Positive topline data from 4SC's resminostat Phase II trial on Hodgkin's Lymphoma

Positive topline data from 4SC's resminostat Phase II trial on Hodgkin's Lymphoma

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Exercise triggers influential stem cells to become bone instead of fat

Exercise triggers influential stem cells to become bone instead of fat

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

AmerisourceBergen completes acquisition of Premier Source

AmerisourceBergen completes acquisition of Premier Source

New clinical data on Bristol-Myers Squibb's NULOJIX to be presented at ESOT 2011 congress

New clinical data on Bristol-Myers Squibb's NULOJIX to be presented at ESOT 2011 congress

BancoVida, CBAI partner to offer umbilical cord blood collection services in Puerto Rico

BancoVida, CBAI partner to offer umbilical cord blood collection services in Puerto Rico

Vertex receives Health Canada approval for INCIVEK to treat hepatitis C

Vertex receives Health Canada approval for INCIVEK to treat hepatitis C

FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL

FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.